Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $789,903.00 |
|---|---|
| Enterprise Value | $747,903.00 |
| Earnings per Share | $0 |
| Beta | 0.7 |
| Outstanding Shares | 87,766,999 |
| P/E Ratio | 3.43 |
|---|---|
| PEG | 8.18 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.08 |
| Enterprise Value to EBIT | 1.39 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Rafarma Pharmaceuticals, Inc. is a diversified pharmaceutical enterprise that manufactures and distributes a range of medicinal products, including generic antibiotics and specialized drugs, within the Russian market. Its product portfol...